R-Biopharm acquires Australian lab equipment manufacturer and molecular biology multiplex specialist

R-Biopharm AG, a leading German biotechnology company operating on a global scale, announced the acquisition of AusDiagnostics.

R-Biopharm is expanding its product portfolio with the addition of the Australian specialist and manufacturer of molecular biology multiplex diagnostics, extraction reagents, and laboratory automation equipment. The company is thereby unlocking new market segments in clinical diagnostics and continuing on its path of steady internationalization. “The existing and future molecular biology multiplex analysis platforms for syndrome testing from system supplier AusDiagnostics broadens our molecular biology expertise and perfectly complements our present clinical diagnostics portfolio,” states Christian Dreher, CEO of R-Biopharm. “The acquisition strengthens our position as a reliable partner for system solutions and offers our customers additional options for diagnostics.”

Comunicat de presă furnizat şi asumat de APA OTS

Citeşte comunicatul în întregime la adresa http://www.comunicate.mediafax.biz/Pages/Public/Comunicate.aspx?comunicatId=16320